This class of drugs, originally used for type 2 diabetes, is now widely used for weight loss because the medications curb appetite, slow digestion, and promote weight loss
For example, in the STEP (Semaglutide Treatment Effect in People) trials , researchers evaluated how much weight individuals could lose with semaglutide compared to a placebo
Broadening use beyond diabetes in tackling comorbidities Perhaps most transformative is that GLP-1 therapies are no longer confined to diabetes alone
doi: 10.3389/fmicb.2014.00504 134 MurataTOkunoYSatoYWatanabeTKimuraH
Neuroprotective Effects Emerging research suggests that GLP-1 agonists may have protective effects against neurodegenerative diseases like Alzheimer's and Parkinson's
As proud members of the local Austin medical community , we are committed to safety, accountability, and compassionate care for every patient we serve